What is the recommended starting dose of Zofran (ondansetron) for adults and children, including intravenous, oral, and sublingual routes?

Zofran Starting Dosing

For chemotherapy-induced nausea/vomiting in adults and children ≥6 months: start with 0.15 mg/kg IV (maximum 16 mg per dose) given 30 minutes before chemotherapy, then repeat at 4 and 8 hours after the first dose; for postoperative nausea/vomiting in adults: give 4 mg IV undiluted over 2-5 minutes immediately before anesthesia induction, and in children ≥1 month to 12 years: give 0.1 mg/kg IV (maximum 4 mg) as a single dose. 1

Chemotherapy-Induced Nausea and Vomiting (CINV)

Adults and Pediatric Patients ≥6 months

• Dose: 0.15 mg/kg per dose for 3 doses (maximum 16 mg per dose) 1
• Preparation: Must dilute in 50 mL of 5% Dextrose or 0.9% Sodium Chloride before administration 1
  • For infants 6 months to 1 year or ≤10 kg: may dilute in 10-50 mL based on fluid needs 1
• Administration: Infuse IV over 15 minutes
  • First dose: 30 minutes before starting chemotherapy
  • Second dose: 4 hours after first dose
  • Third dose: 8 hours after first dose 1

Important caveat: In patients with severe hepatic impairment (Child-Pugh ≥10), reduce to a single maximum daily dose of 8 mg infused over 15 minutes 1

Radiation-Induced Nausea and Vomiting

For high and moderate risk radiation therapy, the ASCO guideline recommends:

• Ondansetron 8 mg oral/oral dissolving tablet/oral soluble film OR 8 mg (or 0.15 mg/kg) IV 2
• Given once daily before radiation therapy on treatment days
• Continue once daily on non-treatment days if radiation was given the day before 2

Postoperative Nausea and Vomiting (PONV)

Adults

• Dose: 4 mg IV undiluted 1
• Administration: Give over 2-5 minutes immediately before induction of anesthesia 1
• Critical point: A second 4 mg dose given postoperatively provides NO additional benefit in patients who received prophylactic dosing 1

Timing consideration: Research suggests that in prolonged surgeries (≥2 hours), administering ondansetron 30 minutes before completion of surgery is significantly more effective for preventing late PONV (2-24 hours) than pre-induction dosing 3

Pediatric Patients (1 month to 12 years)

• Weight ≤40 kg: 0.1 mg/kg IV (maximum 4 mg) as a single dose 1
• Weight >40 kg: 4 mg IV as a single dose 1
• Administration: Undiluted, no specific infusion time required 1

Dose-response data: Studies demonstrate that 0.05 mg/kg is as effective as higher doses (0.1 mg/kg and 0.15 mg/kg) for PONV in children 4, 5, though the FDA label recommends 0.1 mg/kg 1

Alternative Formulations

Oral Dosing

• Chemotherapy setting: After IV loading doses, ondansetron 4 mg oral syrup twice daily can be given for 2 days following cessation of chemotherapy 1
• Oral vs IV equivalence: Studies show oral ondansetron 8 mg syrup plus dexamethasone is as effective as IV ondansetron 5 mg/m² for CINV in children 6

Oral Dissolving Tablets (ODT)

• ODT formulations are better tolerated than oral solutions in children with gastroenteritis, with significantly less early vomiting (2.7% vs 9.5%) 7
• Can use flavored IV ondansetron administered orally when oral formulations unavailable, achieving therapeutic serum levels 8

Critical Pharmacogenetic Consideration

CYP2D6 ultrarapid metabolizers clear ondansetron too quickly, leading to treatment failure 9, 10. If a patient is a known CYP2D6 ultrarapid metabolizer, switch to a non-CYP2D6 metabolized antiemetic like granisetron instead 9, 10.

Combination Therapy

Adding dexamethasone significantly improves ondansetron efficacy:

• CINV: Dexamethasone 4 mg oral or IV with ondansetron 2
• PONV: Dexamethasone 4 mg IV at surgery start enhances ondansetron effectiveness 3